title: Concluding remarks: optimal treatment for women with ovarian cancer.
authors.affiliation: National Cancer Institute, Bethesda, MD 20892-7436, USA. tt6m@nih.gov
authors.forename: Edward L
authors.initials: EL
authors.lastname: Trimble
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*